Azidus Ghana is a Novel Bioequivalence center setup in West Africa by Azidus Laboratories, India.
It is the 1st BA/BE center in Ghana with a goal to ensure quality generic medicines are accessible to all
clinical infrastructure with (2 Clinics) 48 beds & 2 ICU
Bioanalytical infrastructure with 2 LC/MS MS machines, all under single roof.
We provide end to end solutions to the technical needs of Pharmaceutical and Biotechnology industries for the conduct of BA/BE studies, Clinical trials, Clinical Data Management, Pharmacovigilance and Regulatory submission to the Global drug regulatory agencies.
Azidus India team has decade of experience in conducting BA/BE studies and it has been inspected & approved by Major health agencies like USFDA, EMA, ANVISA, WHO, MoH Turkey and many more.
Azidus India has several experience in working on complex molecule BE studies likeLiposomal products (Doxorubicin/Amphotericin), Locally acting drugs (Mesalazine, Pinaverium bromide), endogenous drugs products (phytonadione, ursodiol), Controlled substances and many more.
Azidus India has tremendous amount of experience in BA/BE studies and it provides complete scientific and regulatory advices to Azidus Ghana to ensure all the studies are executed per the regulatory requirements.
At Azidus, we ensure that every study is conducted in accordance with GCP, principles of GLP guidelines and other applicable regulatory requirements. Here, Innovation, Accuracy and Perfection are blended and delivered through a dedicated team of research professionals to exceed customer’s needs.
Azidus holds following principles and values in high esteem and while making decisions in the business.
Azidus has a dedicated volunteer mobilization team which does motivation and mobilization of the volunteers, including adult healthy males & females,
post-menopausal females and geriatric volunteers are registered in the data bank.
Azidus can undertake the following studies.